Virtus Investment Advisers »

Immix Biopharma shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $399k 39k 10.31

More positions owned by Virtus Investment Advisers

Micron Technology (MU)
Datadog Cl A Com (DDOG)
Marvell Technology (MRVL)
Incyte Corporation (INCY)
Applied Materials (AMAT)
Advanced Micro Devices (AMD)
Amgen (AMGN)
Devon Energy Corporation (DVN)
Lam Research Corp Com New (LRCX)
Alnylam Pharmaceuticals (ALNY)
Gilead Sciences (GILD)
Western Digital (WDC)
Kla Corp Com New (KLAC)
Corning Incorporated (GLW)
Regeneron Pharmaceuticals (REGN)

View all positions for Virtus Investment Advisers

Top funds holding Immix Biopharma

Jupiter Topco
Henderson Group
Saturn V Capital Management
Eventide Asset Management
BlackRock
Deep Track Capital
Vanguard Capital Management
Opaleye Management
Millennium Management
UBS Group
Marshall Wace
Wellington Management Company
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Velan Capital Investment Management

View all funds holding Immix Biopharma